Get the SPI Wire

AKARI THERAPEUTICS, PLC

NASDAQ:AKTX
Annual Meeting

of Shareholders

MEETING DATE

10/28/2026
DEF 14A FILED
10/01/2026
PUBLISHED
10/01/2026 9:00 pm
TIME TO PUBLISH
10/03/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:AKTX· CUSIP 00972G207 · CLASS ordinary shares · CIK 0001541157

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

1
FOR
0
AGAINST
0
WITHHOLD
1
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To generally and unconditionally authorize an increase in the number of shares available for the grant of awards under the Company’s 2023 Equity Incentive Plan (the “2023 Plan”) by 144,000,000,000 ordinary shares (the equivalent of 1,800,000 ADSs) to 163,806,000,000 ordinary shares (the equivalent of 2,047,575 ADSs) plus such additional number of ordinary shares (up to 855,637,300 ordinary shares) subject to awards granted under the Celsus Therapeutics PLC 2014 Equity Incentive Plan, to the extent such awards are forfeited or cancelled, or expire unexercised.
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Board states the increase is essential to continue providing long-term equity-based incentives.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

190ebc109303a2e7d85a3069dde82eedd09c3418c13d12704bf89d734c575f5b

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates